Clinical Trial Update: Extracorporeal Photopheresis (ECP) With Methoxsalen for Chronic Graft Versus Host Disease (cGVHD) [EARLY_Phase 1]

View source ↗

Summary

Early phase 1 trial investigating extracorporeal photopheresis with methoxsalen for chronic graft-versus-host disease has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Extracorporeal Photopheresis with Methoxsalen

Snippet

Sponsor: Mallinckrodt | Conditions: Chronic Graft Versus Host Disease | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2019-10-29